176 related articles for article (PubMed ID: 8937516)
1. Oxidized lipoproteins and nitric oxide.
Jessup W
Curr Opin Lipidol; 1996 Oct; 7(5):274-80. PubMed ID: 8937516
[TBL] [Abstract][Full Text] [Related]
2. Endothelium-derived relaxing factor (nitric oxide), lipoprotein oxidation and atherosclerosis.
Bruckdorfer KR; Jacobs M; Rice-Evans C
Biochem Soc Trans; 1990 Dec; 18(6):1061-3. PubMed ID: 2088806
[No Abstract] [Full Text] [Related]
3. Oxidized low density lipoproteins inhibit relaxations of porcine coronary arteries. Role of scavenger receptor and endothelium-derived nitric oxide.
Tanner FC; Noll G; Boulanger CM; Lüscher TF
Circulation; 1991 Jun; 83(6):2012-20. PubMed ID: 2040054
[TBL] [Abstract][Full Text] [Related]
4. Oxidized lipoproteins induce long-lasting inhibition of nitric oxide synthase from a murine endothelioma cell line (bEnd.4).
Fogliatto G; Musanti R; Pirillo A; Ghiselli G
J Cardiovasc Risk; 1995 Apr; 2(2):123-30. PubMed ID: 7541706
[TBL] [Abstract][Full Text] [Related]
5. Antioxidants, lipoprotein oxidation, and arterial function.
Bruckdorfer KR
Lipids; 1996 Mar; 31 Suppl():S83-5. PubMed ID: 8729099
[TBL] [Abstract][Full Text] [Related]
6. The effects of native LDL and oxidized LDL on EDRF bioactivity and nitric oxide production in vascular endothelium.
Myers PR; Wright TF; Tanner MA; Ostlund RE
J Lab Clin Med; 1994 Nov; 124(5):672-83. PubMed ID: 7964125
[TBL] [Abstract][Full Text] [Related]
7. Dual effects of oxidized low-density lipoprotein on immune-stimulated nitric oxide and prostaglandin release in macrophages.
Matthys KE; Van Hove CE; Jorens PG; Rosseneu M; Marescau B; Herman AG; Bult H
Eur J Pharmacol; 1996 Feb; 298(1):97-103. PubMed ID: 8867925
[TBL] [Abstract][Full Text] [Related]
8. Oxidized low density lipoproteins potentiate vasoconstrictions to various agonists by direct interaction with vascular smooth muscle.
Galle J; Bassenge E; Busse R
Circ Res; 1990 May; 66(5):1287-93. PubMed ID: 2335027
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of endothelial derived relaxing factor by oxidized lipoproteins.
Chin JH; Azhar S; Hoffman BB
J Clin Invest; 1992 Jan; 89(1):10-8. PubMed ID: 1309534
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide synthesis in atherosclerosis.
Toutouzas PC; Tousoulis D; Davies GJ
Eur Heart J; 1998 Oct; 19(10):1504-11. PubMed ID: 9820988
[No Abstract] [Full Text] [Related]
11. Apolipoprotein B of low-density lipoprotein impairs nitric oxide-mediated endothelium-dependent relaxation in rat mesenteric arteries.
Zhang Y; Zhang W; Edvinsson L; Xu CB
Eur J Pharmacol; 2014 Feb; 725():10-7. PubMed ID: 24444440
[TBL] [Abstract][Full Text] [Related]
12. A HMG-CoA reductase inhibitor possesses a potent anti-atherosclerotic effect other than serum lipid lowering effects--the relevance of endothelial nitric oxide synthase and superoxide anion scavenging action.
Sumi D; Hayashi T; Thakur NK; Jayachandran M; Asai Y; Kano H; Matsui H; Iguchi A
Atherosclerosis; 2001 Apr; 155(2):347-57. PubMed ID: 11254905
[TBL] [Abstract][Full Text] [Related]
13. Macrophages, endothelial cells, and lipoprotein oxidation in the pathogenesis of atherosclerosis.
Rosenfeld ME; Palinski W; Ylä-Herttuala S; Carew TE
Toxicol Pathol; 1990; 18(4 Pt 1):560-71. PubMed ID: 2091235
[TBL] [Abstract][Full Text] [Related]
14. Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase.
Feron O; Dessy C; Moniotte S; Desager JP; Balligand JL
J Clin Invest; 1999 Mar; 103(6):897-905. PubMed ID: 10079111
[TBL] [Abstract][Full Text] [Related]
15. Oxidized low density lipoproteins alter macrophage lipid uptake, apoptosis, viability and nitric oxide synthesis.
Yang X; Galeano NF; Szabolcs M; Sciacca RR; Cannon PJ
J Nutr; 1996 Apr; 126(4 Suppl):1072S-5S. PubMed ID: 8642435
[TBL] [Abstract][Full Text] [Related]
16. Hypochlorite-oxidized low density lipoproteins reduce production and bioavailability of nitric oxide in RAW 264.7 macrophages by distinct mechanisms.
Schmid W; Lee A; Son J; Koller E; Volf I
Life Sci; 2008 Jul; 83(1-2):50-8. PubMed ID: 18558412
[TBL] [Abstract][Full Text] [Related]
17. L-4F, an apolipoprotein A-1 mimetic, restores nitric oxide and superoxide anion balance in low-density lipoprotein-treated endothelial cells.
Ou Z; Ou J; Ackerman AW; Oldham KT; Pritchard KA
Circulation; 2003 Mar; 107(11):1520-4. PubMed ID: 12654610
[TBL] [Abstract][Full Text] [Related]
18. Chylomicron-remnant-like particles inhibit the basal nitric oxide pathway in porcine coronary artery and aortic endothelial cells.
Goulter AB; Avella M; Botham KM; Elliott J
Clin Sci (Lond); 2003 Sep; 105(3):363-71. PubMed ID: 12757429
[TBL] [Abstract][Full Text] [Related]
19. Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance.
Feron O; Dessy C; Desager JP; Balligand JL
Circulation; 2001 Jan; 103(1):113-8. PubMed ID: 11136695
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide regulation of free radical- and enzyme-mediated lipid and lipoprotein oxidation.
Bloodsworth A; O'Donnell VB; Freeman BA
Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1707-15. PubMed ID: 10894807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
